ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.
Chen Y, Zhao Y, Chen J, Peng C, Zhang Y, Tong R, Cheng Q, Yang B, Feng X, Lu Y, Xie H, Zhou L, Wu J, Zheng S.
Chen Y, et al. Among authors: zheng s.
Mol Cancer. 2020 Aug 10;19(1):123. doi: 10.1186/s12943-020-01239-w.
Mol Cancer. 2020.
PMID: 32772918
Free PMC article.